Providing best-in-class IR/PR counsel to life sciences and healthcare companies since 2000

We leverage our extensive contacts across the U.S. investment community to raise awareness and visibility of our clients among bankers, analysts and investors

We work with private and public companies in all developmental stages to execute financial and strategic transactions

We employ senior-level professionals with more than 25 years of relevant industry experience

EXPERIENCED PROFESSIONALS
ESTABLISHED REPUTATION
HIGHLY RESPONSIVE
STRATEGIC EXPERTISE
INNOVATIVE APPROACH

About Rx Communications

Rx Communications Group is a best-in-class investor relations firm specializing in the life sciences and healthcare industries. We design, implement and execute comprehensive and tailored investor relations, media relations and corporate communications programs for private and publicly traded companies, worldwide, across a broad range of development stages and market capitalizations.

OUR CLIENTS

22nd Century Group, Inc.
Aclipse Therapeutics
Alexandria Real Estate Equities, Inc.
Berkshire Biomedical, LLC
Cerus Endovascular Ltd.
Enterome
Galápagos
Hansa Biopharma AB
Immuneering Corporation
Immunic, Inc.
Immunomic Therapeutics, Inc.
Intensity Therapeutics, Inc.
IVERIC Bio, Inc.
Lutris Pharma
Molecure S.A.
NeuroBo Pharmaceuticals, Inc.
Rejuvitas, Inc.
RenBio, Inc.
Repligen Corporation
Reshape Lifesciences Inc.
Semler Scientific, Inc.
ThermoGenesis Holdings, Inc.